Annual EPS
-$0.94
+$2.64+73.74%
December 31, 2023
Summary
- As of February 23, 2025, MRKR annual earnings per share is -$0.94, with the most recent change of +$2.64 (+73.74%) on December 31, 2023.
- During the last 3 years, MRKR annual EPS has risen by +$5.16 (+84.59%).
- MRKR annual EPS is now at all-time high.
Performance
MRKR EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.26
-$0.01-4.00%
September 30, 2024
Summary
- As of February 23, 2025, MRKR quarterly earnings per share is -$0.26, with the most recent change of -$0.01 (-4.00%) on September 30, 2024.
- Over the past year, MRKR quarterly EPS has stayed the same.
- MRKR quarterly EPS is now -100.22% below its all-time high of $120.00, reached on December 31, 2010.
Performance
MRKR Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.10
+$0.08+6.78%
September 30, 2024
Summary
- As of February 23, 2025, MRKR TTM earnings per share is -$1.10, with the most recent change of +$0.08 (+6.78%) on September 30, 2024.
- Over the past year, MRKR TTM EPS has stayed the same.
- MRKR TTM EPS is now -102.17% below its all-time high of $50.80, reached on June 30, 2016.
Performance
MRKR TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
MRKR EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +73.7% | 0.0% | 0.0% |
| 3 y3 years | +84.6% | 0.0% | 0.0% |
| 5 y5 years | +98.8% | 0.0% | 0.0% |
MRKR EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.8% | -189.7% | +78.2% | -71.9% | +80.3% |
| 5 y | 5-year | at high | +84.6% | -189.7% | +85.6% | -71.9% | +82.8% |
| alltime | all time | at high | +100.0% | -100.2% | +100.0% | -102.2% | +100.0% |
Marker Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.26(+4.0%) | -$1.10(-6.8%) |
| Jun 2024 | - | -$0.25(-7.4%) | -$1.18(+84.4%) |
| Mar 2024 | - | -$0.27(-15.6%) | -$0.64(-31.9%) |
| Dec 2023 | -$0.94(-73.7%) | -$0.32(-5.9%) | -$0.94(-12.1%) |
| Sep 2023 | - | -$0.34(-217.2%) | -$1.07(-31.4%) |
| Jun 2023 | - | $0.29(-150.9%) | -$1.56(-47.3%) |
| Mar 2023 | - | -$0.57(+26.7%) | -$2.96(-17.3%) |
| Dec 2022 | -$3.58(-34.6%) | -$0.45(-45.8%) | -$3.58(-16.7%) |
| Sep 2022 | - | -$0.83(-25.2%) | -$4.30(-13.5%) |
| Jun 2022 | - | -$1.11(-6.7%) | -$4.97(-3.7%) |
| Mar 2022 | - | -$1.19(+1.7%) | -$5.16(-7.4%) |
| Dec 2021 | -$5.47(-10.3%) | -$1.17(-22.0%) | -$5.57(-10.2%) |
| Sep 2021 | - | -$1.50(+15.4%) | -$6.20(-1.6%) |
| Jun 2021 | - | -$1.30(-18.8%) | -$6.30(-1.6%) |
| Mar 2021 | - | -$1.60(-11.1%) | -$6.40(+3.2%) |
| Dec 2020 | -$6.10(+29.8%) | -$1.80(+12.5%) | -$6.20(+12.7%) |
| Sep 2020 | - | -$1.60(+14.3%) | -$5.50(+7.8%) |
| Jun 2020 | - | -$1.40(0.0%) | -$5.10(+4.1%) |
| Mar 2020 | - | -$1.40(+27.3%) | -$4.90(+4.3%) |
| Dec 2019 | -$4.70(-93.9%) | -$1.10(-8.3%) | -$4.70(-85.9%) |
| Sep 2019 | - | -$1.20(0.0%) | -$33.43(-5.6%) |
| Jun 2019 | - | -$1.20(0.0%) | -$35.43(-7.6%) |
| Mar 2019 | - | -$1.20(-96.0%) | -$38.33(-4.5%) |
| Dec 2018 | -$77.50(+568.1%) | -$29.83(+832.3%) | -$40.13(+213.5%) |
| Sep 2018 | - | -$3.20(-22.0%) | -$12.80(-5.2%) |
| Jun 2018 | - | -$4.10(+36.7%) | -$13.50(+16.4%) |
| Mar 2018 | - | -$3.00(+20.0%) | -$11.60(+0.9%) |
| Dec 2017 | -$11.60(+61.1%) | -$2.50(-35.9%) | -$11.50(+2.7%) |
| Sep 2017 | - | -$3.90(+77.3%) | -$11.20(+9.8%) |
| Jun 2017 | - | -$2.20(-24.1%) | -$10.20(+126.7%) |
| Mar 2017 | - | -$2.90(+31.8%) | -$4.50(-53.6%) |
| Dec 2016 | -$7.20(-92.3%) | -$2.20(-24.1%) | -$9.70(-273.2%) |
| Sep 2016 | - | -$2.90(-182.9%) | $5.60(-89.0%) |
| Jun 2016 | - | $3.50(-143.2%) | $50.80(-130.1%) |
| Mar 2016 | - | -$8.10(-161.8%) | -$168.70(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$93.00(-61.3%) | $13.10(-69.0%) | -$164.20(+13.3%) |
| Sep 2015 | - | $42.30(-119.6%) | -$144.90(-26.8%) |
| Jun 2015 | - | -$216.00(+5900.0%) | -$198.00(-925.0%) |
| Mar 2015 | - | -$3.60(-111.1%) | $24.00(-105.5%) |
| Dec 2014 | -$240.00(-58.9%) | $32.40(-400.0%) | -$439.20(-46.2%) |
| Sep 2014 | - | -$10.80(-280.0%) | -$816.00(-9.0%) |
| Jun 2014 | - | $6.00(-101.3%) | -$896.40(-11.0%) |
| Mar 2014 | - | -$466.80(+35.5%) | -$1006.80(+66.1%) |
| Dec 2013 | -$584.40(-48.3%) | -$344.40(+277.6%) | -$606.00(+9.8%) |
| Sep 2013 | - | -$91.20(-12.6%) | -$552.00(-5.0%) |
| Jun 2013 | - | -$104.40(+58.2%) | -$580.80(-39.3%) |
| Mar 2013 | - | -$66.00(-77.3%) | -$956.40(-5.3%) |
| Dec 2012 | -$1130.40(+135.5%) | -$290.40(+142.0%) | -$1010.40(+58.0%) |
| Sep 2012 | - | -$120.00(-75.0%) | -$639.55(-15.8%) |
| Jun 2012 | - | -$480.00(+300.0%) | -$759.55(+90.1%) |
| Mar 2012 | - | -$120.00(-249.2%) | -$399.55(-37.5%) |
| Dec 2011 | -$480.00(-55.6%) | $80.46(-133.5%) | -$639.55(+6.6%) |
| Sep 2011 | - | -$240.00(+100.0%) | -$600.00(-16.7%) |
| Jun 2011 | - | -$120.00(-66.7%) | -$720.00(-53.8%) |
| Mar 2011 | - | -$360.00(-400.0%) | -$1560.01(-7.1%) |
| Dec 2010 | -$1080.00(-89.9%) | $120.00(-133.3%) | -$1680.01(-40.9%) |
| Sep 2010 | - | -$360.00(-62.5%) | -$2843.08(+4.4%) |
| Jun 2010 | - | -$960.00(+100.0%) | -$2723.08(-95.9%) |
| Mar 2010 | - | -$480.00(-54.0%) | -$66.55 K(-2.6%) |
| Dec 2009 | -$10.68 K(-2.2%) | -$1043.07(+334.6%) | -$68.32 K(-11.1%) |
| Sep 2009 | - | -$240.00(-99.6%) | -$76.87 K(-9.7%) |
| Jun 2009 | - | -$64.79 K(+2778.3%) | -$85.11 K(+207.9%) |
| Mar 2009 | - | -$2250.84(-76.5%) | -$27.65 K(-4.1%) |
| Dec 2008 | -$10.93 K(+379.2%) | -$9596.11(+13.2%) | -$28.81 K(+45.4%) |
| Sep 2008 | - | -$8480.32(+15.9%) | -$19.82 K(+71.2%) |
| Jun 2008 | - | -$7320.03(+114.1%) | -$11.58 K(+144.4%) |
| Mar 2008 | - | -$3418.21(+469.7%) | -$4738.21(+88.0%) |
| Dec 2007 | -$2280.01 | -$600.00(+150.0%) | -$2520.01(+31.2%) |
| Sep 2007 | - | -$240.00(-50.0%) | -$1920.01(+14.3%) |
| Jun 2007 | - | -$480.00(-60.0%) | -$1680.01(+40.0%) |
| Mar 2007 | - | -$1200.00 | -$1200.00 |
FAQ
- What is Marker Therapeutics annual earnings per share?
- What is the all time high annual EPS for Marker Therapeutics?
- What is Marker Therapeutics annual EPS year-on-year change?
- What is Marker Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Marker Therapeutics?
- What is Marker Therapeutics quarterly EPS year-on-year change?
- What is Marker Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Marker Therapeutics?
- What is Marker Therapeutics TTM EPS year-on-year change?
What is Marker Therapeutics annual earnings per share?
The current annual EPS of MRKR is -$0.94
What is the all time high annual EPS for Marker Therapeutics?
Marker Therapeutics all-time high annual earnings per share is -$0.94
What is Marker Therapeutics annual EPS year-on-year change?
Over the past year, MRKR annual earnings per share has changed by +$2.64 (+73.74%)
What is Marker Therapeutics quarterly earnings per share?
The current quarterly EPS of MRKR is -$0.26
What is the all time high quarterly EPS for Marker Therapeutics?
Marker Therapeutics all-time high quarterly earnings per share is $120.00
What is Marker Therapeutics quarterly EPS year-on-year change?
Over the past year, MRKR quarterly earnings per share has changed by $0.00 (0.00%)
What is Marker Therapeutics TTM earnings per share?
The current TTM EPS of MRKR is -$1.10
What is the all time high TTM EPS for Marker Therapeutics?
Marker Therapeutics all-time high TTM earnings per share is $50.80
What is Marker Therapeutics TTM EPS year-on-year change?
Over the past year, MRKR TTM earnings per share has changed by $0.00 (0.00%)